Zhang, S., Tian, J., Wang, X., & Liu, C. (2023). PPIs therapy has a negative impact on the clinical outcomes of advanced SCLC patients treated with PD-L1 inhibitors. BMC Pulmonary Medicine, 23(1), 1. https://doi.org/10.1186/s12890-023-02754-4
Chicago-referens (17:e uppl.)Zhang, Sisi, Jing Tian, Xinwei Wang, och Chengxin Liu. "PPIs Therapy Has a Negative Impact on the Clinical Outcomes of Advanced SCLC Patients Treated with PD-L1 Inhibitors." BMC Pulmonary Medicine 23, no. 1 (2023): 1. https://doi.org/10.1186/s12890-023-02754-4.
MLA-referens (9:e uppl.)Zhang, Sisi, et al. "PPIs Therapy Has a Negative Impact on the Clinical Outcomes of Advanced SCLC Patients Treated with PD-L1 Inhibitors." BMC Pulmonary Medicine, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12890-023-02754-4.
